IGF2BP1 and hepatocellular carcinoma: Notably, a previous report showed that ALKBH5-mediated m6A modification of LY6/PLAUR Domain Containing 1 (LYPD1) is recognized by IGF2BP1 and enhances the stability of LYPD1 mRNA in hepatocellular carcinoma [35].